AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2016
Jan 4, 2016
29864_dirs_2016-01-04_9560d782-43ca-4ac6-891d-e9f2586cbdba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2015-12-30
Reporting Person: BOGER JOSHUA S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-30 | Common Stock | M | 10400 | $35.64 | Acquired | 275684 | Direct |
| 2015-12-30 | Common Stock | S | 7300 | $126.98 | Disposed | 268384 | Direct |
| 2015-12-30 | Common Stock | S | 3100 | $127.55 | Disposed | 265284 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-30 | Stock Option (right to buy) | $35.64 | M | 10400 | Disposed | 2016-02-01 | Common Stock (10400) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 13286 | Indirect |
| Common Stock | 122700 | Indirect |
Footnotes
F1: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
F2: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3: Open market sales reported on this line occurred at a weighted average price of $126.98 (range $126.38 to $127.37).
F4: Open market sales reported on this line occurred at a weighted average price of $127.55 (range $127.38 to $127.83).
F5: Fully vested.